<code id='F845B22D08'></code><style id='F845B22D08'></style>
    • <acronym id='F845B22D08'></acronym>
      <center id='F845B22D08'><center id='F845B22D08'><tfoot id='F845B22D08'></tfoot></center><abbr id='F845B22D08'><dir id='F845B22D08'><tfoot id='F845B22D08'></tfoot><noframes id='F845B22D08'>

    • <optgroup id='F845B22D08'><strike id='F845B22D08'><sup id='F845B22D08'></sup></strike><code id='F845B22D08'></code></optgroup>
        1. <b id='F845B22D08'><label id='F845B22D08'><select id='F845B22D08'><dt id='F845B22D08'><span id='F845B22D08'></span></dt></select></label></b><u id='F845B22D08'></u>
          <i id='F845B22D08'><strike id='F845B22D08'><tt id='F845B22D08'><pre id='F845B22D08'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:655
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline
          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Baby aspirin cuts fat buildup in liver disease patients, in small study

          PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis